HPV Archive — Page 1 of 2
-
March 8, 2018
Awareness, education goal of new HPV initiative
Vanderbilt is at the epicenter of a human papillomavirus (HPV)-associated cancer epidemic, according to Ronald Alvarez, MD, chair of the Department of Obstetrics and Gynecology at Vanderbilt. -
July 12, 2017
Conference to focus on link between viruses and cancer
The association between tobacco use and cancer is well known. But there are other risk factors for cancer that are less recognized, including the link between cancer and certain viruses. -
May 11, 2017
Researchers seek best ways to increase HPV vaccination rates
Tennessee has one of the lowest human papillomavirus (HPV) vaccination rates in the nation, and investigators at Vanderbilt University Medical Center (VUMC) are hoping to change this by improving the way medical providers present these vaccines to patients and by improving patient and patient family education. -
February 2, 2017
National Cancer Institute’s Lowy details HPV virus research efforts
Douglas Lowy, M.D., acting director of the National Cancer Institute (NCI), warned that worldwide death rates from cervical cancer are expected to increase in low- and middle-income countries during the next 15 years unless steps are taken to prevent the cancer from occurring. Almost all cases of cervical cancer are linked to a viral infection. -
January 17, 2017
Vanderbilt-Ingram Cancer Center supports national HPV vaccination efforts
Nearly 39,000 new cancers associated with the human papillomavirus (HPV) will be diagnosed in the United States this year. Although HPV vaccines can prevent the majority of these cancers, vaccination rates remain low across the country. -
February 4, 2016
VICC joins other major cancer centers in HPV vaccine campaign
In response to low national vaccination rates for the human papillomavirus (HPV), Vanderbilt-Ingram Cancer Center (VICC) has joined 68 of the nation’s other NCI-designated cancer centers in recommending increased HPV vaccination for the prevention of cancer. -
June 19, 2014
HPV-positive head and neck cancer patients may receive lower radiation dose
A new study suggests that lowering the dose of radiation therapy for some head and neck cancer patients may improve outcomes and cause fewer long-term side effects.